Furthermore, it inhibits ferroptosis through the SIRT1/Nrf2 pathway, improving fatty liver disease (Yang et al., 2023), and blocks NLRP3-Caspase-1-GSDMD-mediated pyroptosis in H9C2 and RAW264.7 cells (Sun et al., 2023). Here, SIRT1 is linked to fatty liver disease.